2015 American Transplant Congress » Poster Session D: Liver Transplantation for Hepatocellular Carcinoma

Date: Tuesday, May 5, 2015

Time: 5:30pm-6:30pm

Location: Exhibit Hall E

Session Type: Poster Session

Meeting: 2015 American Transplant Congress

5:30pm-6:30pm: Advanced Imaging Modalities for Hepatocellular Carcinoma: Is MRI With Eovist Really Better?

M. Chen, H. Reich, M. Uffenheimer, Y. Nasseri, A. Annamalai.

5:30pm-6:30pm: Alpha-Fetoprotein as a Modifier of Anatomic Criteria for Transplantation of HCC Patients

A. Daoud,^1,3 M. Ghobrial,¹ L. Teeter,² E. Graviss,² E. Asham,¹ S. Burroughs,¹ A. Saharia,¹ C. Mobley,¹ S. Mogawer,³ A. Sholkamy,³ M. Elshazly,⁴ M. Boktour,¹ A. Gaber.¹

5:30pm-6:30pm: An Analysis of Health-Related Quality of Life in Liver Transplantion for Hepatocellular Carcinoma

C. Kensinger, H. O'Dell, D. LaNeve, L. Simmons, I. Feurer, D. Moore.

5:30pm-6:30pm: Association Between Polymorphisms of PPM1E Gene and Tumor Size of Hepatocellular Carcinoma Patients

M.-S. Park,¹ S.-K. Kim.²

5:30pm-6:30pm: Associations Between Sirolimus Use and Outcomes After Liver Transplant for Hepatocellular Carcinoma

E. Yanik,¹ S. Chinnakotla,² A. Israni,^2,3 J. Snyder,^2,3 S. Gustafson,³ E. Engels.¹

5:30pm-6:30pm: Characteristics and Outcomes of Patients With Incidental Hepatocellular Carcinoma Detected in the Explanted Liver Following Transplant

M. Goh, J. Ali, G. Pettigrew.

5:30pm-6:30pm: Clinical Impact of 18F-FDG-PET/CT in Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma

S. Lee, S. Kim.

5:30pm-6:30pm: Impact of Everolimus On the Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplantation When Used in Early Stage: A Single Center Prospective Study

L. Jeng, A. Thorat, H. Yang, C.-C. Yeh, T.-H. Chen, S.-C. Hsu.

5:30pm-6:30pm: Listing for Liver Transplantation of Patients With Hepatocellular Carcinoma Using the Extended Toronto Criteria; an Intention-to-Treat Analysis

G. Sapisochin, N. Goldaracena, J. Laurence, A. Barbas, M. Dib, A. Ghanekar, M. Selzner, L. Lilly, I. McGilvray, M. Cattral, E. Renner, P. Greig, D. Grant.

5:30pm-6:30pm: Liver Transplantation for Hepatocellular Carcinoma inside Milan Criteria: Lower Recurrence in Patients With Hepatitis C Infection

W. Palmer, D. Lee, J. Burns, A. Keaveny, J. Melendez, J. Nguyen, T. Patel, S. Pungpapong, B. Rosser, R. Paz-Fumagalli, R. Nakhleh, K. Musto, D. Harnois.

5:30pm-6:30pm: Liver Transplantation for Primary Liver Malignancies Vs. Neuroendocrine Metastases: Analysis of the UNOS Dataset

V. Vilchez,¹ M. Shah,¹ M. Daily,¹ S. Krohmer,² D. Davenport,¹ E. Maynard,¹ R. Gedaly.¹

5:30pm-6:30pm: Long-Term Outcome After Liver Transplantation for Unresectable Hepatocellular Carcinoma Following Yttrium-90 Radioembolization Bridging Treatment

S. Radunz,¹ T. Benkoe,¹ J. Best,² A. Bockisch,³ T. Lauenstein,⁴ H. Baba,⁵ A. Paul,¹ J. Treckmann.¹

5:30pm-6:30pm: Long-Term Survival Outcomes of Liver Transplantation for Klatskin Tumour: A Comparative Study With Radical Resection Surgery

A. Hu, X. Zhu, X. He.

5:30pm-6:30pm: Longitudinal Trends in Wait Times and Use of Bridging Locoregional Therapies in Hepatocellular Carcinoma Patients undergoing Orthotopic Liver Transplantation: UNOS Population Study

M. Xing, H. Kim.

5:30pm-6:30pm: Modified Upper Abdominal Organ Cluster Transplantation: A Serial of 16 Cases in a Single Center

J. Zhou, W. Ju, X. Yuan, D. Wang, X. Zhu, X. He.

5:30pm-6:30pm: Outcomes of Patients With Hepatocellular Carcinoma Receiving a Donation After Cardiac Death Liver Graft

W. Goldkamp,¹ J. Vanatta,^2,3 S. Nair,^2,3 E. Wong,³ N. Dbouk.^2,3

5:30pm-6:30pm: Recurrence of Hepatocellular Carcinoma After Transarterial Chemoembolization (TACE) Alone and TACE in Combination With Other Treatment Modalities

J. Balogh, A. Islam, A. Saharia, H. Monsour, S. Gordon Burroughs, M. Weiner, A. Gaber, R. Ghobrial.

5:30pm-6:30pm: Risk of Post Liver Transplant (LT) Hepatocellular Carcinoma (HCC) Recurrence Is 2-Fold Higher in Women Compared to Men With AFP Levels at LT Between 101-500

M. Sarkar,¹ J. Dodge,² F. Yao,¹ J. Roberts,² N. Terrault,¹ N. Mehta.¹

5:30pm-6:30pm: SBRT(Stereotactic Body Radiotherapy) to Bridge or Down-Size HCC for Liver Transplantation

N. Thai,¹ K. Tom,¹ M. Szramowski,¹ P. Abrams,¹ J. Oliva,³ D. Monga,⁴ M. Raj,⁴ D. Parda,² A. Kirichenko.²

5:30pm-6:30pm: The Negative Impact of Hepatitis C Infection (HCV+) On Orthotopic Liver Transplantation (OLT) for Hepatocellular Carcinoma (HCC)

A. Daoud,^1,3 L. Teeter,² E. Graviss,² S. Burroughs,¹ A. Gaber.¹

5:30pm-6:30pm: The use of Donation After Cardiac Death Liver Allografts does not increase Recurrence of Hepatocellular Carcinoma

K. Croome, D. Lee, J. Burns, J. Nguyen, D. Perry, D. Harnois, C. Taner.

5:30pm-6:30pm: Unrecognized Synchronous Hepatocellcular Carcinoma Lesions in Explanted Liver Transplant Specimens

D. Aufhauser, Jr.,¹ K. Eddinger,¹ E. Furth,² P. Abt,¹ M. Levine.¹

5:30pm-6:30pm: Verification of OPTN Hepatocellular Carcinoma Recurrence Data

J. George,¹ K. Eddinger,¹ D. Goldberg,² M. Levine,³ P. Abt.³

« View all sessions from the 2015 American Transplant Congress